ArticleThe Lancet regional health. Europe2021

Patients' access to drugs with rebates in Switzerland - Empirical analysis and policy implications for drug pricing in Europe.

David L Carl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.